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Abstract
Objective—We examined contraceptive use and dual protection in the post-partum period in a 
Prevention of Mother to Child Transmission (PMTCT) population and whether it varied by HIV 
status.
Study Design—Data are from a prospective study, the South Africa HIV Antenatal Post-test 
Support Study. Pregnant participants were recruited from a government clinic in an urban 
township and the analytic sample was 821. Following enrollment, participants were tested for HIV 
and administered a questionnaire at baseline and 14 weeks post-partum. We used generalized 
linear regression models to examine HIV status and use of modern contraceptives at 14 weeks.
Results—The risk ratio of condom use at 14 weeks post-partum was 1.66 (95% CI: 1.36-2.02) 
for HIV positive compared to HIV negative women. The risk ratio for dual protection (use of a 
condom and a hormonal method) was 1.96 (95% CI: 1.39-2.79) at 14 weeks for HIV positive 
compared to HIV negative women.
Conclusions—HIV positive status may be a motivating factor for women to use condoms and 
dual protection. In this setting where HIV is highly prevalent it is ever more important that women 
control the timing and limiting of births so as to preserve the health of the mother and child.
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South Africa is home to the largest population of HIV infected persons worldwide (6.1 
million) and the adult (ages 15-49) HIV prevalence in South Africa is 17.9% (1). Sixty 
percent of HIV infected adults over the age of 15 are women in their childbearing years, and 
most HIV positive women are infected with HIV before the age of 25 (2). Fertility rates in 
South Africa are quite low, and most South African women want two children on average 
(3). Current contraceptive use among sexually active women is dominated by the injectable 
(32%), followed by the pill (12%), female sterilization (10%), male or female condom (8%), 
IUD (0.5%), and male sterilization (0.5%) (3). In the last 40 years, contraceptive use 
increased, resulting in declining fertility rates and lengthened birth intervals (4, 5). However, 
half of births in the five years before the last Demographic and Health Survey were 
unintended and many first births are mistimed (3).
The South African government initiated a Prevention of Mother to Child Transmission 
(PMTCT) program in 2001. The PMTCT program goals are to improve HIV testing, engage 
HIV positive women in care and treatment, prevent HIV infections in children, and avoid 
future HIV positive births through modern contraceptive use. Modern contraceptive use as a 
PMTCT intervention has the potential to avert 120,256 HIV positive births in South Africa 
yearly (6).
The evidence on whether HIV status affects women's fertility desires in sub-Saharan Africa 
is mixed. Authors of several studies found that women who know they are HIV positive do 
not want more children. Upon receiving an HIV diagnosis, HIV positive women in Rwanda 
and Zimbabwe were more likely to report that they did not want any more children 
compared to HIV negative women (7, 8). In contrast, authors of a number of other studies in 
South Africa, Kenya and Uganda found that knowledge of positive HIV status increases 
women's fertility desire (9-11). Researchers from Zambia, Zimbabwe, Cote d'Ivoire, Kenya, 
Rwanda, South Africa and Tanzania found HIV status did not affect fertility desire because 
social, cultural and health factors outweighed HIV status on decisions about childbearing 
(12-14).
Authors from several sub-Saharan African countries found that when PMTCT clients learn 
their HIV positive status it increases their contraceptive use; however, in most studies, 
increases in contraceptive use did not persist long-term. In a prospective cohort study of 
women in Lilongwe, Malawi the authors assessed the effects of learning one's HIV status on 
contraceptive use and found that use initially increased among HIV positive women, but 
decreased over time (15). In South Africa, the authors of a study of a PMTCT population in 
KwaZulu-Natal found that the odds of condom use were higher for HIV positive compared 
to HIV negative women (16). The authors of another South African study examining any 
modern contraceptive use in the post-partum period in a PMTCT population in Eastern Cape 
found no differences in contraceptive use between HIV negative and positive women, but 
the authors did not control for demographic variation among women (17).
The key to sustaining contraceptive use among PMTCT attendees may be intervening during 
the post-partum period when women are in contact with the healthcare system and motivated 
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to use contraception after learning their HIV status. We examined post-partum contraceptive 
use in a PMTCT population and whether it varied by HIV status. We hypothesized that HIV 
positive women would be more likely than HIV negative women to use contraceptives and 
dual protection in the post-partum period.
Materials and Methods
The South Africa HIV antenatal post-test support study
Data are from a prospective study, the South Africa HIV Antenatal Post-test Support Study 
(SAHAPS), a randomized controlled trial examining the efficacy of an integrated model of 
HIV post-test support for women attending antenatal care in Durban, South Africa. One 
thousand five hundred pregnant women attending antenatal care at a government clinic in an 
urban township were enrolled in the study between 2007-2010. Women were randomized at 
baseline to standard World Health Organization (WHO)/Centers for Disease Control and 
Prevention (CDC) HIV counseling and testing or an enhanced counseling and testing 
intervention. The enhanced counseling and testing intervention included counseling about 
partner HIV testing, counseling on family planning methods and access to a lawyer to help 
with social issues. Following the baseline questionnaire and randomization, women were 
counseled and tested for HIV, so women learned their HIV status before making decisions 
about contraceptive methods. Women were then followed longitudinally at 6 weeks post-
partum, 10 weeks, 14 weeks and 9 months. This study relies on data from questionnaires 
administered at baseline and 14 weeks post-partum because 6 and 10 week contraceptive 
data had many missing values and 9 month data were not available to include in the analysis 
because these are preliminary results.
Eligibility
Pregnant women who presented to the clinic for antenatal care were eligible for screening. 
Inclusion criteria were: (1) at least 18 years old, (2) had never tested for HIV or had tested 
negative for HIV at least 3 months prior to recruitment, (3) had a primary intimate partner 
for at least the past 6 months, (4) planned to live in Durban for at least the next year, (5) 
planned to bring their infant to the clinic for immunization visits, (6) able to communicate in 
English or Zulu, and (7) did not need critical care for a high risk pregnancy. SAHAPS is a 
collaborative study between the University of KwaZulu-Natal (UKZN) located in Durban 
and the University of North Carolina at Chapel Hill (UNCCH), and has been approved by 
institutional review boards at both institutions.
Interview procedures
Women were recruited from the antenatal clinic at the study site. Women who met eligibility 
criteria and gave informed consent were interviewed in Zulu or English by a trained 
interviewer at baseline and 14 weeks. HIV testing was conducted by a study nurse at the first 
antenatal visit and a separate consent process was used for HIV testing. Interviews lasted 
one to one and a half hours and participants were remunerated with 70 Rand (~U.S. $8) at 
each visit for transportation.
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One thousand fifteen hundred women completed the baseline questionnaire, however, 20 
women refused to test for HIV during the study and were excluded. Of the 1,480 women 
who completed a questionnaire at baseline and tested for HIV, 1,154 (78%) also completed a 
follow-up questionnaire at 14 weeks post-partum. Women who were pregnant (N=1) or not 
sexually active (N=275) at 14 weeks were excluded from the analyses. Further, 32 women 
were missing data on modern contraceptive use at 14 weeks or other variables and were 
excluded. Therefore the final analysis sample of 821 included women who completed a 
baseline and follow-up questionnaire, tested for HIV, were sexually active at 14 weeks and 
had data on modern contraceptive use at 14 weeks.
Analysis
We used generalized linear regression with a log link and binomial distribution to examine 
the relationships of interest. The dependent variables were condom use and dual protection 
(use of a condom (male or female) and a hormonal method at the same time) at 14 weeks. 
The independent variable was HIV status. We examined descriptive statistics for all 
variables and tested differences between HIV positive and negative women using t-tests (for 
continuous variables) and chi squared tests (for categorical variables). We used control 
variables identified in the literature associated with HIV status and contraceptive use. The 
control variables included: age, relationship duration, education level, religion, marital 
status, employment status, whether the partner had tested for HIV, age at first sex, number 
of sexual partners, socioeconomic status, ever contraceptive use, parity and intervention 
arm. We used the same control variables for all models. HIV status (positive or negative) 
was recorded in a baseline medical file. Analyses were conducted using Stata 11 (18).
Models
We used generalized linear regression with a log link and binomial distribution to estimate 
relative risk (18). In the first model, the dependent variable is a measure of condom use at 14 
weeks. Women currently using condoms were coded as yes and those not using condoms 
were coded no. In the second model, we created the dependent variable dual protection. 
Dual protection is when a woman used both a condom and another hormonal method. 
Women using dual protection were coded yes and those not coded no. The main independent 
variable of interest in both models is HIV status.
Results
Of the 821 women included in the analytic sample, 64.7% were HIV negative (N=531) and 
35.3% (N=290) were HIV positive (see Table 1). The average age for HIV positive women 
was 26 and 25 for HIV negative women. Most women had either a middle school (grades 8 
to 11) or high school (matric) education. Very few women were married and most were 
partnered but not living together. A majority of women did not know if their partner had 
tested for HIV. The average age at first sex reported by women was 18 years old (range: 
9-34) and this did not differ by HIV status. Women reported an average of 2.5 lifetime 
sexual partners (range: 1-28) and the average was higher for HIV positive women (2.9 
partners) compared to HIV negative women (2.4 partners). Sixty three percent of HIV 
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positive and 65% of HIV negative women had ever used a contraceptive method. The two 
groups were balanced on covariates except for ever contraceptive use. See Table 1 for more 
details.
The risk ratio of condom use at 14 weeks post-partum for HIV positive women was 1.66 
times (95% CI: 1.35-2.01) that of HIV negative women (see Table 2). The risk ratio of dual 
protection for HIV positive women was 1.97 times (95% CI: 1.39-2.79) that of HIV negative 
women (see Table 2).
Discussion
Our findings suggest that there is an association between knowledge of positive HIV status 
and post-partum contraceptive use and dual protection. A strength of our study is the 
prospective cohort design. Ever use of contraceptives was similar at baseline and we 
controlled for this in our model, thus strengthening our findings. However, other research in 
sub-Saharan Africa suggests that this effect is short-term, usually lasting a few months. A 
prospective cohort study of women in Lilongwe, Malawi assessed the effects of learning 
one's HIV status on contraceptive use up to one year after diagnosis. Contraceptive use 
initially increased among HIV positive women, but decreased over time (15). Similar results 
were found in Kigali, Rwanda, where HIV positive women had initial higher contraceptive 
use compared to HIV negative women, but use in both groups declined after one and two 
years, primarily due to contraceptive discontinuation (7). Another study of HIV sero-
discordant couples in Lusaka, Zambia showed initial increases in contraceptive use, but no 
impact on pregnancy incidence, and high levels of user failure and discontinuation (19). 
After a few months, user failure and contraceptive discontinuation, or other changing factors 
such as fertility desire and socioeconomic circumstances, appear to become more important 
than HIV status alone, in the decision to use modern contraceptives.
In our study, many women learned their HIV status for the first time and this provided them 
the behavioral motivation in the post-partum period to use contraceptives. This motivation is 
important because a majority of women in South Africa, and in our study, do not know their 
partner's HIV status. Women using dual protection are able to protect partners from 
infection or from becoming infected, as well as protecting future offspring if they were to 
become pregnant again. Prior research indicates that women are amenable to contraceptive 
adoption in the post-partum period and that it may be an ideal time to counsel women about 
modern contraceptive use (20). PMTCT programs should capitalize on their motivation 
during this period to educate women about how to overcome issues of user failure and 
discontinuation.
Although we only examined post-partum contraceptive use in our study, previous research 
suggests the importance of addressing health facility and social factors to promote continued 
contraceptive use after the post-partum period. In sub-Saharan Africa, recent studies suggest 
several health systems factors that may influence women's contraceptive adoption and merit 
additional investigation. These factors include: the contraceptive method mix offered at 
government health facilities, contraceptive counselor's level of knowledge about 
contraceptive methods, waiting times at public health facilities and service integration 
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(Voluntary Counseling and Testing-VCT, Family Planning-FP, Maternal and Child Health-
MCH) (21, 22).
Limitations
Three hundred twenty six participants (22%) did not return at 14 weeks and 20 participants 
(1%) refused to test for HIV during the study. Participants lost to follow-up were similar to 
participants who completed a 14-week visit, except for HIV status. Women lost to follow-up 
were more likely to be HIV positive. HIV status appears to affect post-partum contraceptive 
use in this study and therefore may potentially overestimate our results. Fourteen weeks is a 
short time period for follow-up. We wanted to include measures of ART use and exclusive 
breastfeeding in our analysis but did not have good data on these variables.
Conclusion
We sought to understand whether knowledge of HIV status is associated with women's post-
partum contraceptive use in an urban clinic in Durban, South Africa. Our study contributes 
additional evidence that HIV status may be a motivating factor for women to use condoms 
and dual protection. In this setting where HIV is highly prevalent it is ever more important 
that women control the timing and limiting of births so as to preserve the health of the 
mother and child.
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• HIV status may be an important motivating behavioral factor for women to 71 
use contraceptives and dual protection in the post-partum period.
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Table 1
Sample Characteristics (N=821)
Variable HIV Positive-N=290 HIV Negative-N=531 P-value
*
Condom Use 0.000
Yes 128 (44%) 145 (27%)
Dual Protection 0.000
Yes 61 (21%) 62 (12%)
Intended to Use Contraception 0.942
Yes 213 (73%) 373 (70%)
Age 0.001
Years (range) 26 (18-44 ) 25 (18-45)
Education Level 0.000
Primary or less 21 (7%) 29 (5%)
    Grades 8 to 11- Matric 142 (49%) 197 (37%)







Christian 221 (76%) 434 (82%)
Traditional/African 54 (19%) 69 (13%)
Other 15 (5%) 28 (5%)
Marital status 0.003
Married 12 (4%) 48 (9%)
Partner-living together 81 (28%) 105 (20%)
Partner-not living together 197 (68%) 378 (71%)
Relationship duration 0.000
Years (range) 4 (0.5-23) 5 (0.5-26)
Employment status 0.006
Housewife 128 (44%) 234 (44%)
Employed 133 (46%) 202 (38%)




Partner has tested for HIV 0.001
Yes 78 (27%) 205 (39%)
Age at first sex 0.003
Years (range) 18 (12-26 ) 18 (11-34)
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Variable HIV Positive-N=290 HIV Negative-N=531 P-value
*
Number of sex partners 0.000
Number (range) 2.9 (1-10) 2.4 (1-28)
Socio-economic status-Number of household assets 0.019
Number (range) 5.0 (0-9) 5.3 (0-9)
Ever contraceptive use 0.903
Yes 185 (64%) 341 (64%)
Parity 0.042
One birth 98 (34%) 215 (40%)
Two births 127 (44%) 186 (35%)




Intervention 154 (53%) 273 (51%)
Control 136 (47%) 258 (49%)
*
T-tests were used for continuous variables and chi-squared tests for categorical variables
**
Does not equal 100% due to rounding
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Table 2
Results from Generalized Linear Regression
Model 1-Condom Use Relative Risk 
(Confidence Interval)
Model 2-Dual Protection Relative 
Risk (Confidence Interval)





Intended to Use Contraception 0.87 (0.70-1.09) 0.86 (0.60-1.25)













Beyond matric 1.22 (0.85-1.75) 1.19 (0.60-2.37)
Religion
Christian Referent Referent
Traditional/African 0.93 (0.71-1.24) 1.07 (0.68-1.70)
Other 0.84 (0.53-1.33) 0.96 (0.45-2.04)
Marital status






Partner-not living together Referent Referent
Relationship duration 1.01 (0.98-1.04) 1.03 (0.99-1.09)
Employment status
Housewife Referent Referent
Employed 1.05 (0.85-1.30) 1.03 (0.73-1.47)
Student 1.04 (0.76-1.41) 0.87 (0.50-1.54)
Unemployed 0.77 (0.37-1.61) 1.14 (0.40-3.28)
Partner has tested for HIV 0.98 (0.79-1.21) 0.92 (0.64-1.32)
Age at first sex 0.99 (0.94-1.03) 1.05 (0.97-1.14)
Number of sex partners 1.03 (0.99-1.08) 0.95 (0.83-1.08)











One birth 1.11 (0.87-1.42) 1.13 (0.75-1.70)
Two births Referent Referent
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Model 1-Condom Use Relative Risk 
(Confidence Interval)
Model 2-Dual Protection Relative 
Risk (Confidence Interval)
Three or more births 1.09 (0.82-1.45) 0.92 (0.56-1.52)
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